The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas

Modern Pathology

Volumn 12, Issue 5, 1999, Pages 539-545

  Plank, Tracey L ^a   Logginidou, Helen ^a   Klein Szanto, Andres ^a   Henske, Elizabeth Petri ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Angiomyolipoma; Hamartin; Tuberin; Tuberous sclerosis complex; Tumor suppressor gene

Indexed keywords

HAMARTIN; TUBERIN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADRENAL CORTEX; ANGIOMYOLIPOMA; ARTICLE; BRAIN; BRAIN CORTEX; CONTROLLED STUDY; GENE MUTATION; HEART; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY TUBULE EPITHELIUM; KIDNEY TUMOR; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; THYROID FOLLICLE CELL; TISSUE DISTRIBUTION; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ANGIOMYOLIPOMA; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; BRAIN; ENDOCRINE GLANDS; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY TUBULES; LUNG; MUSCLE, SKELETAL; MYOCARDIUM; PROTEIN BIOSYNTHESIS; PROTEINS; REPRESSOR PROTEINS; TISSUE DISTRIBUTION; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 0032924220     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Bjornsson J, Short MP, Kwiatkowski DJ, Henske EP. Tuberous sclerosis-associated renal cell carcinoma: clinical, pathologic, and genetic features. Am J Pathol 1996;149:1201-8.
2. Al-Saleem T, Wessner L, Scheithauer BW, Patterson K, Roach ES, Dreyer SJ, et al. Malignant tumors of the kidney, brain, and soft tissues in children and young adults with tuberous sclerosis. Cancer 1998;83:2208-16.
3. Pea M, Bonetti F, Martignoni G, Henske EP, Manfrin E, Colato C, et al. Apparent renal cell carcinomas in tuberous sclerosis are heterogeneous: the identification of malignant epithelioid angiomyolipoma. Am J Surg Pathol 1998;22:180-7.
4. European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 1993;75:1305-15.
5. van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M, Janssen B, Verhoef S, et al. Identification of the tuberous sclerosis gene, TSC1, on chromosome 9q34. Science 1997; 277:805-8.
6. van Slegtenhorst M, Nellist M, Nagelkerken B, Cheadle J, Snell R, van den Ouweland A, et al. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Hum Mol Genet 1998;7:1053-7.
7. Plank TL, Yeung RS, Henske EP. Hamartin, the product of the tuberous sclerosis-1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles. Cancer Res 1998;58:4766-70.
8. Carbonara C, Longa L, Grosso E, Borrone C, Garre MG, Brisigotti M, et al. 9q34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also for the TSC1 gene. Hum Mol Genet 1994;3:1829-32.
9. Green AJ, Smith M, Yates JRW. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nat Genet 1994;6:193-6.
10. Green AJ, Johnson PH, Yates JRW. The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor. Hum Mol Genet 1994;3:1833-4.
11. Henske EP, Neumann HPH, Scheithauer BW, Herbst EW, Short MP, Kwiatkowski DJ. Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas. Genes Chromosom Cancer 1995;13:295-8.
12. Henske EP, Scheithauer BW, Short MP, Wollmann R, Nahmias J, Hornigold N, et al. Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am J Hum Genet 1996;59:400-6.
13. Henske EP, Wessner LL, Golden J, Scheithauer BW, Vortmeyer AO, Zhuang Z, et al. Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors. Am J Pathol 1997;151:1639-47.
14. Wienecke R, Maize JC, Reed J, deGunzburg J, Yeung RS, DeClue JE. Expression of the TSC2 product, tuberin, and its target, Rapl, in normal human tissues. Am J Pathol 1997; 150:43-50.
15. Menchine M, Emelin JK, Mischel PS, Haag TA, Norman MH, Pepkowitz SH, et al. Tissue and cell-type specific expression of the tuberous sclerosis gene, TSC2, in human tissues. Mod Pathol 1996;9:1071-80.
16. Kerfoot C, Wienecke R, Menchine M, Emelin J, Maize JC, Welsh CT, et al. Localization of tuberous sclerosis-2 mRNA and its protein product tuberin in normal human brain and in cerebral lesion of patients with tuberous sclerosis. Brain Pathol 1996;6:367-77.
17. Kapur RP, Bigler SA, Skelly M, Gown AM. Antimelanoma monoclonal antibody HMB-45 identifies an oncofetal glycoconjugate associated with immature melanosomes. J Histochem Cytochem 1992;40:207-12.
18. Bacchi CE, Bonetti F, Pea M, Martignoni G, Gown AM. HMB-45: a review. Appl Immunohistochem 1996;4:73-85.
19. Pea M, Bonetti F, Zamboni G, Martignoni G, Riva M, Colombari R, et al. Melanocyte marker HMB-45 is regularly expressed in angiomyolipoma of the kidney. Pathology 1991; 23:185-8.
20. Wienecke R, Maize JC, Shoarinejad F, Vass WC, Reed J, Bonifacino JS, et al. Co-localization of the TSC2 product, tuberin, with its target, Rap1, in the Golgi apparatus. Oncogene 1996;13:913-23.
21. Xiao GH, Shoarinejad F, Jin F, Golemis EA, Yeung RS. The tuberous sclerosis-2 gene product, tuberin, functions as a Rab5GAP in modulating endocytosis. J Biol Chem 1997;272: 6097-100.
22. Stenmark G, Vitale G, Ullrich O, Zerial M. Rabaptin-5 is a direct effector of the small GTPase Rab5 in endocytic membrane fusion. Cell 1995;83:423-32.
23. Bucci C, Parton RG, Mather IH, Stunnenberg H, Simons K, Hoflack B, et al. The small GTPase Rab5 functions as a regulatory factor in the early endocytic pathway. Cell 1992; 70:715-28.